Navigation Links
Trachoma cannot be obliterated with just one dose of antibiotic

A study carried in eight Ethiopian villages for two years found that a single dose of an antibiotic is insufficient to nip infection causing trachoma, which happens to be the// primary cause of blindness.

A previous study in one Tanzanian village had seemed to show that a single distribution exercise of one antibiotic was enough to completely negate the infection. A new study has suggested that the infection relapses after two years.

“I think it's actually good news,” said study co-author Dr. Tom Lietman of the University of California San Francisco. “While it comes back, it comes back very slowly.”

The findings suggest that, azithromycin, administered twice a year has the potential to totally obliterate the infection, according to Lietman. The study has found a place in the Journal of the American Medical Association.

Young children show higher tendencies of contracting the infection, which ultimately results in blindness. Trachoma is known to afflict an estimated 84 million people worldwide, and the poor in Africa seem to show a tendency to contract it.


'"/>




Page: 1

Related medicine news :

1. New Test For Detecting Trachoma
2. Blindness And Trachoma
3. Trachoma not Curable by Antibiotics Alone
4. Newly Identified Strains Of Chlamydia Trachomatis – A Gateway To New Disease
5. Gay men cannot donate sperm
6. Cause of ‘Down Syndrome’ cannot be pinned down to maternal age aloe
7. New antibiotic already developing resistance
8. Gene clue to antibiotics
9. Excessive use of antibiotics for sore throat
10. E. coli strains resistant to a common antibiotic
11. Cost-effective antibiotics for sinusitis treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... METTLER TOLEDO has ... personnel have a basic understanding of the techniques they use so they can ... help them reduce waste and rework to create a leaner overall lab experience. ...
(Date:2/9/2016)... ... ... i2i Systems, an early innovator and developer of population health management technology, ... report, Population Health Management 2015: How Far Can Your Vendor Take You? , ... The latest KLAS Report, leveraging over 200 user interviews, shines a light on ...
(Date:2/8/2016)... ... 08, 2016 , ... Brenntag Specialties, Inc.(BSI) , is ... & Beverage and Dietary Supplement market segments across the western ... geographies east of the Rocky Mountains since 2012. Consistent performance in business ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... L top-load case packer for pouches, bags, and flow wrapped products at WestPack ... co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case packing ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency ... Venice, FL area, has initiated a fundraiser for a two year old little ... days after Christmas. To support this beautiful child who is facing life’s journey ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... ORLANDO, Florida , February 9, 2016 /PRNewswire/ ... QIA) today announced a collaboration with 10x Genomics ... sequencing (NGS), single-cell biology and bioinformatics. --> ... announced a collaboration with 10x Genomics to develop ... single-cell biology and bioinformatics. --> QIAGEN ...
(Date:2/9/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a ... and heart failure, today announced that it intends to offer ... in an underwritten public offering.  The offering is subject to ... as to whether or when the offering may be completed, ... offering.   --> --> ...
Breaking Medicine Technology: